Previous Close | 24.23 |
Open | 24.06 |
Bid | 9.77 x 1200 |
Ask | 26.86 x 900 |
Day's Range | 23.93 - 24.57 |
52 Week Range | 17.56 - 32.00 |
Volume | |
Avg. Volume | 232,629 |
Market Cap | 938.432M |
Beta (5Y Monthly) | 0.85 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.89 |
Earnings Date | Mar 28, 2022 - Apr 01, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 31.00 |
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
LATHAM, N.Y., August 03, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference at 2:00 p.m. ET on Wednesday, August 10, 2022.